Table S1. Patients’ clinical and biological characteristics. Table S2. Characteristics of brain metastases. Table S3. Univariate analysis of OS (A) in the whole MBC population (n = 244) and (B) in the BM population (n = 86): additional results. (DOCX 75 kb
Table S1. CD8 levels distribution according to tumor subtype and clinicopathological features. (DOCX...
Table S1. Linear regression coefficients for association between the tumor size (mm) and selected pa...
Table S1. Circulating concentrations of OPG and risk of death following a breast cancer diagnosis, b...
Table S1. Source, clone, and dilution of the antibodies used. Table S2. Basal clinicopathologic char...
Table S1. Univariable and multivariable analysis of overall survival in breast cancer patients. Tabl...
Is Table S1 presenting a description of study populations, Table S2 presenting KI67 immunohistochemi...
Figure S1. KaplanâMeier survival analysis of baseline hematologic parameters (NLR, PLR), TILs CD8+...
Supplementary Figures and Tables. This file contains the following figures and tables: Validation of...
Table S2. FOXP3 levels distribution according to tumor subtype and clinicopathological features. (DO...
Figure S1. Forest plot of mRNA expression of m6A enzymes for metastasis relapse (MR)-free survival i...
Analysis of 120 clinically annotated plasma samples from the Komen Tissue Bank, representing 40 samp...
Multivariate analysis of DDFS and BCSS for all patients, including PAM50 intrinsic subtypes. (DOC 49...
Figure S1. Overall survival for HER2+ patients according to CD8/FOXP3 ratio. (PPTX 80 kb
Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...
Table S1. Clinical trials. Results of clinical trials as provided by ( https://www.clinicaltrials.go...
Table S1. CD8 levels distribution according to tumor subtype and clinicopathological features. (DOCX...
Table S1. Linear regression coefficients for association between the tumor size (mm) and selected pa...
Table S1. Circulating concentrations of OPG and risk of death following a breast cancer diagnosis, b...
Table S1. Source, clone, and dilution of the antibodies used. Table S2. Basal clinicopathologic char...
Table S1. Univariable and multivariable analysis of overall survival in breast cancer patients. Tabl...
Is Table S1 presenting a description of study populations, Table S2 presenting KI67 immunohistochemi...
Figure S1. KaplanâMeier survival analysis of baseline hematologic parameters (NLR, PLR), TILs CD8+...
Supplementary Figures and Tables. This file contains the following figures and tables: Validation of...
Table S2. FOXP3 levels distribution according to tumor subtype and clinicopathological features. (DO...
Figure S1. Forest plot of mRNA expression of m6A enzymes for metastasis relapse (MR)-free survival i...
Analysis of 120 clinically annotated plasma samples from the Komen Tissue Bank, representing 40 samp...
Multivariate analysis of DDFS and BCSS for all patients, including PAM50 intrinsic subtypes. (DOC 49...
Figure S1. Overall survival for HER2+ patients according to CD8/FOXP3 ratio. (PPTX 80 kb
Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...
Table S1. Clinical trials. Results of clinical trials as provided by ( https://www.clinicaltrials.go...
Table S1. CD8 levels distribution according to tumor subtype and clinicopathological features. (DOCX...
Table S1. Linear regression coefficients for association between the tumor size (mm) and selected pa...
Table S1. Circulating concentrations of OPG and risk of death following a breast cancer diagnosis, b...